Real-World Outcomes Study on Subjects Treated With Radiofrequency Ablation

(ROSTRA Trial)

Recruiting in Palo Alto (17 mi)

+10 other locations

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Abbott Medical Devices

No Placebo Group

Trial Summary

What is the purpose of this trial?

ROSTRA is an international, prospective, non-randomized, single-arm, multi-center, and post-market study to collect real-world safety and effectiveness data on Abbott's IonicRF™Generator and compatible RFA accessories. This post-market study is intended to satisfy EU MDR requirements.

Eligibility Criteria

Inclusion Criteria

A. All candidate subjects

Subject must provide written informed consent prior to any clinical investigation-related procedure

Subject is ≥ 18 years of age

Treatment Details

Interventions

• IonicRF Generator and compatible accessories (Radiofrequency Ablation)

Participant Groups

Group I: IonicRF Generator and compatible accessories Experimental Treatment 1 Intervention

IonicRF Radiofrequency Generator, along with any country-specific market-released accessory (i.e. electrode, cannula, grounding pad, and adaptor cable) compatible with the IonicRF Generator will be used.

Find a Clinic Near You

Research Locations Nearby Select from list below to view details:

Nevada Advanced Pain Specialists Reno, NV

Ainsworth Institute of Pain Management New York, NY

The Spine & Nerve Center of St Francis Hospital Charleston, WV

Nura Edina, MN

Who Is Running the Clinical Trial?

Abbott Medical Devices Lead Sponsor

References